ABT vs. PHG: Abbott Laboratories vs. Koninklijke Philips Stock Comparison

Company Profile

Abbott Laboratories (ABT) and Koninklijke Philips (PHG) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Abbott Laboratories (ABT) trades as ordinary local shares, while Koninklijke Philips (PHG) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Abbott Laboratories (ABT) at 9.14% and Koninklijke Philips (PHG) at 8.61% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Abbott Laboratories (ABT) at 9.75% retains a top-quartile share of revenue as profit, ahead of Koninklijke Philips (PHG) at 5.39%, which keeps about the industry-typical share.

Both Abbott Laboratories (ABT) at 11.66% and Koninklijke Philips (PHG) at 3.76% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

Abbott Laboratories (ABT) at 5.67% is around its peer norm for revenue growth, while Koninklijke Philips (PHG) at -1.04% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Only one side can be read here: Abbott Laboratories (ABT) reports EPS growth of -51.31%, ranked against its industry; Koninklijke Philips (PHG) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Abbott Laboratories (ABT) at 1.46 keeps current ratio within its industry’s typical mid-range, while Koninklijke Philips (PHG) at 1.33 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for PHG.

Both Abbott Laboratories (ABT) at 0.61 and Koninklijke Philips (PHG) at 0.70 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Koninklijke Philips (PHG) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a yield of 2.22%, ranking against industry peers normally.

Koninklijke Philips (PHG) reports payout ratio above 100% at 211.79%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Abbott Laboratories (ABT) reports 92.54%, ranking against industry peers normally.

Dividend Metrics

Valuation

Abbott Laboratories (ABT) at 41.02 is near its industry’s usual P/E ratio, while Koninklijke Philips (PHG) at 63.23 sits in the richer quartile — PHG needs stronger growth or earnings quality to justify the premium.

On P/S ratio, both Abbott Laboratories (ABT) at 3.95 and Koninklijke Philips (PHG) at 1.67 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

On P/B ratio, both Abbott Laboratories (ABT) at 3.73 and Koninklijke Philips (PHG) at 2.28 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics